About Magellan Life Sciences
Magellan Life Sciences is a company based in Hyderabad (India) founded in 2013. Magellan Life Sciences operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Magellan Life Sciences Private Limited
- Date of Incorporation 22 Oct, 2013
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
Not available
-
Net Profit
-$406.03 (USD)89.32as on Mar 31, 2022
-
EBITDA
-$103.58 (USD)98.52as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Roquette
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Magellan Life Sciences
Investors in Magellan Life Sciences
Magellan Life Sciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Roquette and SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Plant-based pharma, nutraceuticals, and cosmetics are manufactured as a CDMO.
|
Locked | Locked | Locked |
Investor details for Magellan Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Magellan Life Sciences
Investment portfolio details for Magellan Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Magellan Life Sciences
Detailed financials for Magellan Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Magellan Life Sciences Comparisons
Peer comparison for Magellan Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Magellan Life Sciences
Magellan Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Magellan Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Magellan Life Sciences
Complete news archive for Magellan Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magellan Life Sciences
Magellan Life Sciences was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Magellan Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Develops natural non-caloric sweetener along with proprietary vaccines, biologics, and food biotech products. In the vaccines division, the company is developing subunit vaccine antigens for tropical diseases such as malaria, chikungunya, dengue, Ebola, and MERS. In the biologicals division, it is developing protein therapeutics for Diabetes, Cancer, Arthritis, etc. In the food biotech division, it is developing protein-based food supplements called Magellan PALATES, which include non-sugar sweeteners Brazzein isolated from exotic fruit Oubli, antimicrobial and coagulating agents, etc. Also, it has a service division named BacMam (Baculovirus mediated gene transfer into Mammalian cells) for protein expression and purification, along with protein analysis and characterization services, and it claims to be the only company in Asia offering BacMam protein expression platform service.
Magellan Life Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.